» Articles » PMID: 23222874

Multicomponent Indices to Predict Survival in COPD: the COCOMICS Study

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2012 Dec 11
PMID 23222874
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Guidelines recommend defining chronic obstructive pulmonary disease (COPD) by airflow obstruction and other factors, but no studies have evaluated the ability of existing multicomponent indices to predict mortality up to 10 years. We conducted a patient-based pooled analysis. Survival analysis and C statistics were used to determine the best COPD index/indices according to several construct variables and by varying time-points. Individual data of 3633 patients from 11 COPD cohorts were collected, totalling the experience of 15 878 person-years. Overall, there were 1245 death events within our cohorts, with a Kaplan-Meier survival of 0.963 at 6 months, which was reduced to 0.432 at 10 years. In all patients, ADO (age, dyspnoea and forced expiratory volume in 1 s), BODE (body mass index, airflow obstruction, dyspnoea and exercise capacity) and e-BODE (BODE plus exacerbations) were the best indices to predict 6-month mortality. The ADO index was the best to predict 12-month (C statistic 0.702), 5-year (C statistic 0.695) and 10-year mortality (C statistic 0.698), and was significantly better than BODE (all p<0.05). The best indices to predict death by C statistics when adjusting by age were e-BODE, BODEx (substitution of exacerbations for exercise capacity) and BODE. No index predicts short-term survival of COPD well. All BODE modifications scored better than ADO after age adjustment. The ADO and BODE indices are overall the most valid multicomponent indices to predict time to death in all COPD patients.

Citing Articles

Contribution of Anemia to Multidimensional Indices for Predicting Mortality in Hospitalized Patients With Chronic Obstructive Pulmonary Disease (COPD).

Garcia-Pachon E, Padilla-Navas I Cureus. 2024; 16(10):e72126.

PMID: 39575004 PMC: 11580708. DOI: 10.7759/cureus.72126.


Prognostic models and factors identifying end-of-life in non-cancer chronic diseases: a systematic review.

Gebresillassie B, Attia J, Mersha A, Harris M BMJ Support Palliat Care. 2024; 14(e3):e2316-e2329.

PMID: 38580395 PMC: 11672066. DOI: 10.1136/spcare-2023-004656.


Characteristics and phenotypes of a COPD cohort from referral hospital clinics in Uganda.

Alupo P, Mugenyi L, Katagira W, Kayongo A, Nalunjogi J, Siddharthan T BMJ Open Respir Res. 2024; 11(1).

PMID: 38490695 PMC: 10946361. DOI: 10.1136/bmjresp-2023-001816.


The Relationship between Exertional Desaturation and Pulmonary Function, Exercise Capacity, or Medical Costs in Chronic Obstructive Pulmonary Disease Patients.

Tsai M, Li C, Chang H, Tsai Y, Tseng C, Liu S Medicina (Kaunas). 2023; 59(2).

PMID: 36837592 PMC: 9963049. DOI: 10.3390/medicina59020391.


External Validation and User Experiences of the ProPal-COPD Tool to Identify the Palliative Phase in COPD.

Broese J, van der Kleij R, Verschuur E, Kerstjens H, Bronkhorst E, Chavannes N Int J Chron Obstruct Pulmon Dis. 2022; 17:3129-3138.

PMID: 36579356 PMC: 9792220. DOI: 10.2147/COPD.S387716.